Myositis Research

Coote D, Davis MR, Cabrera M, Needham M, Laing NG, Nowak KJ. Clinical Utility Gene Card for: Becker muscular dystrophy. Eur J Hum Genet. 2018; 26(7):1065-1071. doi: 10.1038/s41431-017-0064-4.

Advances in inclusion body myositis: genetics, pathogenesis and clinical aspects Needham M, Mastaglia F Expert Opinion on Orphan Drugs, Volume 5, Issue 5, 4 May 2017, Pages 431-443 [Scimago – Quartile, Q2; Rank, 14,070]

A Systematic Review and Meta-Analysis of Prevalence Studies of Sporadic Inclusion Body Myositis Callan, A., Capkun, G., Vasanthaprasad, V., Freitas, R., Needham, M Journal of Neuromuscular Diseases 4(2), pp. 127-137, 2017 [Scimago – Quartile, Q2; Rank, 6,261]

Mortality and causes of death in patients with sporadic inclusion body myositis: survey study based on the clinical experience of specialists in Australia, Europe and the USA. Price MA, Barghout V, Benveniste O, Christopher-Stine L, Corbette A, de Visser M, Hilton-Jones D, Kissel JT, Lloyd TE, Lundberg IE, Mastaglia F, Mozaffar T, Needham M, Schmidt J, Sivakumar K, DeMuro C, Tseng BS. Journal of Neuromuscular Disorders. 2016; 3(1):67-75

Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women. Bates KA, Sohrabi HR, Rainey-Smith SR, Weinborn M, Bucks RS, Rodrigues M, Beilby, Howard M, Taddei K, Martins G, Paton A, Shah T, Dhaliwalh SS, Foster JK, Martins IJ, Lautenschlager NT, Mastaglia FL, Gandy S, Martins RN. International Journal of Neuroscience. 2016 April 25. [Epub ahead of print]. DOI:10.1080/00207454.2016.1182527

Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale, Gutteridge DH, Mastaglia FL, Internal Medicine Journal (accepted for publication November 2016).

Sporadic Inclusion Body Myositis: A Review of Recent Clinical Advances and Current Approaches to Diagnosis and Treatment, Needham M, Mastaglia F, Clinical Neurophysiology. 2016; 127(3)1764-1773. PMID:26778717

Immunotherapies for Immune-Mediated Myopathies. A Current Perspective. Needham M, Mastaglia FL, Neurotherapeutics. 2016; 13(1):132-146. PMID:26586486. PMCID:4720681.

Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies. van der Stap DK, Rider LG, Alexanderson H, Huber AM, Gualano B, Gordon P, van der Net J, Mathiesen P, Johnson LG, Ernste FC, Feldman BM, Houghton KM, Singh-Grewal D, Kutzbach AG, Munters LA, Takken T; International Myositis Assessment and Clinical Studies Group (including Mastaglia F). Journal of Rheumatology 2016; 43(1):169-176. PMID:26568594. PMCID:4698199

Diagnostic performance of a commercial Immunoblot assay for myositis antibody testing. Bundell C, Rojana-udomsart A, Mastaglia F, Hollingsworth P, McLean-Tooke A. Pathology. 2016; 48(4); 363-366. PMID:27114370